Skip to content
Open access

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Sep 2026 · Chemical Biology and Drug Design · Vol 108 · 0 citations · 53 references
Medicine

TL;DR

Findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents and suggest InhA as a potential molecular target.

Abstract

A series of novel benzisothiazole‐based hydrazide derivatives was rationally designed, synthesized, and evaluated for their antitubercular activity. Among the synthesized compounds, derivative 8k emerged as the most potent candidate, exhibiting a minimum inhibitory concentration (MIC) of 0.25 μg/mL, along with a high selectivity index (SI) of 42 and confirmed bactericidal activity. To gain preliminary insights into its possible mechanism of action, compound 8k was subjected to molecular docking and 100 ns molecular dynamics simulations, using enoyl‐acyl carrier protein reductase (InhA) as the proposed molecular target. The computational studies revealed favorable binding interactions and a relatively stable protein–ligand complex, suggesting InhA as a potential molecular target. However, experimental target‐validation studies are required to confirm direct InhA inhibition and establish the proposed mechanism of action. Furthermore, in silico ADMET predictions indicated favorable pharmacokinetic characteristics and drug‐likeness properties for the lead compound. Collectively, these findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents.

Read PDF

Similar papers

Open access Sep 2026

Design and in silico screening of novel isoniazid-based Schiff base derivatives followed by synthesis and biological evaluation of the lead compound against Mycobacterium tuberculosis H37Rv

The findings suggest that isoniazid-based Schiff base derivatives represent a promising scaffold for the development of new antitubercular agents, with SLB-5 emerging as a promising candidate for further investigation.

Shivani L. Bhuse, P. M. Patil, Rajat R. Durbule · 0 citations
Open access Sep 2026

Vanillin-Derived Multifunctional Agents: Structure-Based Design, Docking, and In Vitro Evaluation of Antitubercular, Anti-Inflammatory, and Antioxidant Activities

Tuberculosis remains a major global health burden, highlighting the urgent need for new therapeutic agents with improved efficacy and safety. In this study, a series of vanillin-derived biphenyl ether analogues inspired by the nimesulide scaffold was designed and synthesized as multifunctional candidates targeting tube...

S. R., V. B. Hacholli, Ł. Szeleszczuk et al. · 0 citations
Open access Sep 2026

Synthesis and Antifungal Evaluation of Isoquinoline‐3‐amide Derivatives Containing a Phenoxypyridine Moiety for Plant Protection

To discover novel green antifungal candidates, 20 3‐acylaminoisoquinoline derivatives were designed and synthesized by introducing the active fragment phenoxypyridine. Their structures were verified by 1H NMR, 13C NMR, and HRMS. The structure of compound X9 was further confirmed via X‐ray crystallography. Their antifun...

Jia-Yao Zhang, Shuai-Peng Sun, Ya-Jing Guo et al. · 0 citations
Open access Sep 2026

Synthesis, Biological Evaluation, and In Silico Studies of Naphtalene‐Hydrazide Derivatives as Dual‐Action Agents for Alzheimer's Disease: Targeting BChE and Oxidative Stress

Interestingly, compounds 7a and 8a exhibited five‐fold higher selectivity for BChE than AChE, suggesting their potential relevance for further exploration in the context of Alzheimer's disease therapeutics.

Dilan Konyar, Hayati Okur, M. T. Muhammed et al. · 0 citations
Open access Sep 2026

Rational design and synthesis of sulfonamide-substituted coumarinyl-imidazolone hybrids against multidrug-resistant microbial strains: computational and biological evaluation studies.

In vitro findings identified compounds 6a, 6m, and 6n as potent leads, exhibiting significant antimicrobial activity with minimum inhibitory concentration values ranging from 15 to 500 µg/mL and antioxidant activity with DPPH IC50 values of 6.35 ± 0.51 μM, respectively.

Preetesh Kumar Panda, S. Paidesetty, Alaka Sahoo et al. · 0 citations
Open access Sep 2026

Exploration of novel indolo[2,3-b]quinoxaline hybrids as InhA inhibitors: A multi-disciplinary approach involving synthesis, antimycobacterial evaluation and computational studies.

A library of 52 indolo[2,3-b]quinoxaline derivatives was designed and synthesized using a pharmacophore-hybridization strategy and subjected to comprehensive biological and computational evaluation, highlighting indolo[2,3-b]quinoxaline as promising antitubercular scaffold for further development.

Sri Mounika Bellapukonda, Akanksha, Mainak Ghosh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.